TerminatedNCT00508157
Effects of Aripiprazole Versus Other Atypical Antipsychotics for Metabolic Syndrome; Schizophrenia
Medication studyAges 18–65Multiple countries
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Brussels and 29 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2007
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 125
- Sponsor
- Bristol-Myers Squibb
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- France, Switzerland, Belgium, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00508157
- Official title
Show the full official title
A 16-Week, Multicenter, Randomized, Open-label Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
Recruitment & locations
TerminatedBrussels, Belgium · Brno, Czechia · Havířov, Czechia
23 more locations
- Hradec Králové, Czechia
- Prague, Czechia
- Přerov, Czechia
- Roudnice nad Labem, Czechia
- Fains-Véel, France
- Lille, France
- Limoges, France
- Montpellier, France
- Paris, France
- Poitiers, France
- Strasbourg, France
- Ellwangen, Germany
- Werneck, Germany
- Chania-Crete, Greece
- Corfu, Greece
- Budapest, Hungary
- Gyula, Hungary
- Oviedo, Spain
- Barcelona, Spain
- Wetzikon, Switzerland
- Izmir, Türkiye
- Czechia
- Türkiye
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Bristol-Myers Squibb, a pharmaceutical company.
Does this study involve medication?
Yes. The study involves medication, including Aripiprazole and Continued Antipsychotic (Risperidone or Quetiapine or Olanzapine).
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
